T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Founded by Christoph Kasper and Simon J. Ittig in 2015, T3 Pharmaceuticals is backed by investors that include Boehringer Ingelheim Venture Fund and Reference Capital SA and is headquartered in Basel.
INDUSTRY:
Biotechnology, Life Science, Therapeutics
FOUNDERS:
Christoph Kasper, Simon J. Ittig
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
